ArticlePloS one2013

Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine.

Yushi Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.